AKT1 and supranuclear palsy, progressive, 1: FoundationOne CDx multigene panel test identified AKT1 E17K, a common mutation in PSP [7], and two TP53 mutations (R280T and E287K) with a low tumor mutation burden (3 muts/Mb).